Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trials

被引：0
|
作者：
Caiyun Zheng
Meimei Lin
Yan Chen
Haiting Xu
Lingqun Yan
Hengfen Dai
机构：
[1] Affiliated Fuqing City Hospital of Fujian Medical University,
[2] Fujian Medical University,undefined
[3] Affiliated Fuzhou First Hospital of Fujian Medical University,undefined
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Sodium glucose cotransporter type 2 inhibitors; Cardiovascular disease; Mortality; Meta‐analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
    Haiyan Cao
    Xiaosheng Rao
    Junya Jia
    Tiekun Yan
    Dong Li
    Acta Diabetologica, 2023, 60 : 325 - 335
  • [32] Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
    Cao, Haiyan
    Rao, Xiaosheng
    Jia, Junya
    Yan, Tiekun
    Li, Dong
    ACTA DIABETOLOGICA, 2023, 60 (03) : 325 - 335
  • [33] Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials
    Tsai, Wan-Chuan
    Hsu, Shih-Ping
    Chiu, Yen-Ling
    Yang, Ju-Yeh
    Pai, Mei-Fen
    Ko, Mei-Ju
    Tu, Yu-Kang
    Hung, Kuan-Yu
    Chien, Kuo-Liong
    Peng, Yu-Sen
    Wu, Hon-Yen
    BMJ OPEN, 2022, 12 (10):
  • [34] Letter on "Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials"
    Mo, Manqiu
    Xia, Ning
    Liao, Yunhua
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 346 : 35 - 35
  • [35] Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease
    Tamara Y. Milder
    Sophie L. Stocker
    Dorit Samocha-Bonet
    Richard O. Day
    Jerry R. Greenfield
    European Journal of Clinical Pharmacology, 2019, 75 : 1481 - 1490
  • [36] Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review
    Rahman, Hammad
    Khan, Safi U. U.
    Lone, Ahmad N. N.
    Ghosh, Priyanka
    Kunduru, Mahathi
    Sharma, Saurabh
    Sattur, Sudhakar
    Kaluski, Edo
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (16):
  • [37] Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years
    Liu, Xiang-Yang
    Zhang, Ning
    Chen, Rui
    Zhao, Jia-Guo
    Yu, Pei
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1295 - 1303
  • [38] Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes
    Chilton, Robert J.
    DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 16 - 29
  • [39] Effects of sodium-glucose cotransporter 2 inhibitors on non-alcoholic fatty liver disease in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Xing, Baodi
    Zhao, Yuhang
    Dong, Bingzi
    Zhou, Yue
    Lv, Wenshan
    Zhao, Wenjuan
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (05) : 1238 - 1247
  • [40] Sodium glucose cotransporter2 inhibitors for type 1 diabetes mellitus: A meta-analysis of randomized controlled trials
    Nan, Juanli
    Wang, Dekai
    Zhong, Ruxian
    Liu, Fen
    Luo, Jingmei
    Tang, Ping
    Song, Xiaoxiao
    Zhang, Lihua
    PRIMARY CARE DIABETES, 2024, 18 (01) : 17 - 24
12345